An adrenergic beta-3-receptor agonist for use as a medicament for treatment of an aging-related disease is disclosed. The adrenergic beta-3-receptor agonist is selected from one of CL316243, N-5984, BMS-194449, BMS-196085, CP114271, CP80625, BRL 37344, SR58611A, TAK2677, and N25984.